Correlation Between BANK RAKYAT and CITIUS PHARMAC
Can any of the company-specific risk be diversified away by investing in both BANK RAKYAT and CITIUS PHARMAC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining BANK RAKYAT and CITIUS PHARMAC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between BANK RAKYAT IND and CITIUS PHARMAC DL, you can compare the effects of market volatilities on BANK RAKYAT and CITIUS PHARMAC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in BANK RAKYAT with a short position of CITIUS PHARMAC. Check out your portfolio center. Please also check ongoing floating volatility patterns of BANK RAKYAT and CITIUS PHARMAC.
Diversification Opportunities for BANK RAKYAT and CITIUS PHARMAC
0.84 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between BANK and CITIUS is 0.84. Overlapping area represents the amount of risk that can be diversified away by holding BANK RAKYAT IND and CITIUS PHARMAC DL in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CITIUS PHARMAC DL and BANK RAKYAT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on BANK RAKYAT IND are associated (or correlated) with CITIUS PHARMAC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CITIUS PHARMAC DL has no effect on the direction of BANK RAKYAT i.e., BANK RAKYAT and CITIUS PHARMAC go up and down completely randomly.
Pair Corralation between BANK RAKYAT and CITIUS PHARMAC
Assuming the 90 days trading horizon BANK RAKYAT IND is expected to generate 0.48 times more return on investment than CITIUS PHARMAC. However, BANK RAKYAT IND is 2.09 times less risky than CITIUS PHARMAC. It trades about 0.0 of its potential returns per unit of risk. CITIUS PHARMAC DL is currently generating about -0.04 per unit of risk. If you would invest 26.00 in BANK RAKYAT IND on October 7, 2024 and sell it today you would lose (3.00) from holding BANK RAKYAT IND or give up 11.54% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 99.8% |
Values | Daily Returns |
BANK RAKYAT IND vs. CITIUS PHARMAC DL
Performance |
Timeline |
BANK RAKYAT IND |
CITIUS PHARMAC DL |
BANK RAKYAT and CITIUS PHARMAC Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with BANK RAKYAT and CITIUS PHARMAC
The main advantage of trading using opposite BANK RAKYAT and CITIUS PHARMAC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if BANK RAKYAT position performs unexpectedly, CITIUS PHARMAC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CITIUS PHARMAC will offset losses from the drop in CITIUS PHARMAC's long position.BANK RAKYAT vs. WT OFFSHORE | BANK RAKYAT vs. EIDESVIK OFFSHORE NK | BANK RAKYAT vs. Tower Semiconductor | BANK RAKYAT vs. PACIFIC ONLINE |
CITIUS PHARMAC vs. Superior Plus Corp | CITIUS PHARMAC vs. NMI Holdings | CITIUS PHARMAC vs. SIVERS SEMICONDUCTORS AB | CITIUS PHARMAC vs. Talanx AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio |